DOW INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that DOW INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.97B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $42.96B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $44.62B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $56.90B | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $54.97B | Jan 31, 2024 |
| FY2021 | Dec 31, 2020 | $38.54B | Feb 4, 2022 |
| FY2021 | Dec 31, 2019 | $42.95B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $49.60B | Feb 5, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.57B | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | $1.34B | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | $744.00M | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | $1.54B | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | $1.49B | Feb 5, 2021 |
| FY2020 | Sep 30, 2019 | $1.39B | Feb 5, 2021 |
| FY2020 | Jun 30, 2019 | $1.59B | Feb 5, 2021 |
| FY2020 | Mar 31, 2019 | $1.83B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.85B | Feb 7, 2020 |
| FY2019 | Sep 30, 2018 | $2.18B | Feb 7, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.39B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $1.58B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $1.63B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $1.68B | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $1.65B | Jan 31, 2024 |
| FY2022 | Dec 31, 2020 | $1.47B | Feb 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.59B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $1.78B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $1.80B | Feb 7, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $2.91B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $5.20B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $7.48B | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $7.01B | Jan 31, 2024 |
| FY2022 | Dec 31, 2020 | $6.23B | Feb 1, 2023 |
| FY2021 | Dec 31, 2019 | $5.93B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $4.25B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | ($4.93B) | Feb 7, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.54B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $57.31B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $57.97B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $60.60B | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $62.99B | Jan 31, 2024 |
| FY2022 | Dec 31, 2020 | $61.47B | Feb 1, 2023 |
| FY2020 | Dec 31, 2019 | $60.52B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $83.70B | Feb 7, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.01B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $17.36B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $18.61B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $20.72B | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $18.17B | Jan 31, 2024 |
| FY2022 | Dec 31, 2020 | $12.44B | Feb 1, 2023 |
| FY2021 | Dec 31, 2019 | $13.54B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $32.48B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $31.52B | Feb 7, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.98B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $8.57B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $8.64B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $8.64B | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $8.76B | Jan 31, 2024 |
| FY2022 | Dec 31, 2020 | $8.91B | Feb 1, 2023 |
| FY2021 | Dec 31, 2019 | $8.80B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $9.85B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $9.83B | Feb 7, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.78B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $20.91B | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $21.77B | Feb 4, 2025 |
| FY2023 | Dec 31, 2022 | $23.18B | Jan 31, 2024 |
| FY2022 | Dec 31, 2021 | $20.62B | Feb 1, 2023 |
| FY2021 | Dec 31, 2020 | $16.36B | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $17.05B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $35.46B | Feb 7, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.82B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $2.19B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $2.99B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $3.89B | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $2.99B | Jan 31, 2024 |
| FY2022 | Dec 31, 2020 | $5.10B | Feb 1, 2023 |
| FY2021 | Dec 31, 2019 | $2.37B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $2.72B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $6.19B | Feb 7, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $15.06B | Feb 1, 2023 |
| FY2022 | Dec 31, 2021 | $14.51B | Feb 1, 2023 |
| FY2021 | Dec 31, 2020 | $16.95B | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $16.41B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $19.59B | Feb 7, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Jan 31, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 1, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | 6 | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 7, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Jan 31, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 1, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | 6 | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 7, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $1.97B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $1.97B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $2.01B | Feb 4, 2025 |
| FY2023 | Dec 31, 2021 | $2.07B | Jan 31, 2024 |
| FY2022 | Dec 31, 2020 | $2.07B | Feb 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.55B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $0 | Feb 5, 2021 |